COVID-19 Vaccine Distribution Plan

For deployment of Pfizer and Moderna vaccines

Phase Phase I Phase II Phase III

High-risk population groupings Mass delivery groupings Steady state
2.8 2.0 3.1
431k 458k 266k 300k 643k 660k 157k
M M M
Populations General
Congregate living Health care Adults in First Adult chronic Adults > 80 Adults 60-79 At-risk Frontline Individuals with Individuals living
population
for seniors workers Nations, Métis, home care (then decreasing in populations essential workers high-risk chronic and working in
(residents, staff, and Inuit recipients 5-year increments conditions and other high-risk
essential caregivers, populations to include up to their caregivers congregate
other employees) 8.5 M adults 16-59) settings

Expected
Doses
Transition to Phase II
Hospital Site Clinics
Congregate living for seniors Public Health-led Mass Vaccination Sites (incl. continued hospital sites) – Demographic and Occupational Focus
Health care workers (patient-facing) (non-patient facing )

Adults > 80 Older adults, decreasing in five-year increments (79 → 75 → 70 → 65…)

Vaccination Frontline essential workers (e.g. first responders, teachers and other education staff, food processing industry)
Mass Site Pilot
Sites and
Priority On-Site Clinics (and Primary Care)
Populations On-Reserve First Nations residents Primary Care / Pharmacies / Public Health Clinics – Medical/Clinical Risk
Served Adults > 80 Older adults, decreasing in five-year increments (79 → 75 → 70 → 65…)

(populations identified Adult chronic home care Individuals with high-risk chronic conditions and their caregivers
are not exclusive to
each site—PHU Remaining eligible Ontarians
guidance will be
utilized to determine
how each population Mobile Sites – Social and Geographical Focus
is best served) Congregate living for seniors

Northern / remote First Nations communities

Urban Indigenous (including First Nations, Métis, and Inuit adults)

People who live and work in other high-risk congregate settings

Populations/communities facing barriers related to the determinants of health who are at greater COVID-19
As of 18 February 2021
risk